Discontinuation rate and factors predictive of the use of hydroxychloroquine in LUMINA, a multiethnic US cohort (LUMINA XL)
- 1 October 2006
- journal article
- Published by SAGE Publications in Lupus
- Vol. 15 (10), 700-704
- https://doi.org/10.1177/0961203306072426
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrualArthritis & Rheumatism, 2005
- Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort{Lupus, 2002
- The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas—a randomized trialDiabetes Research and Clinical Practice, 2002
- Insulin-sparing effect of hydroxychloroquine in diabetic rats is concentration dependentCanadian Journal of Physiology and Pharmacology, 1999
- A Long-Term Study of Hydroxychloroquine Withdrawal on Exacerbations in Systemic Lupus ErythematosusLupus, 1998
- Biochemical characterization of ADP-ribose polymer metabolism in SLELupus, 1996
- Continuation of long term treatment with hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis.Annals Of The Rheumatic Diseases, 1992
- A Randomized Study of the Effect of Withdrawing Hydroxychloroquine Sulfate in Systemic Lupus ErythematosusNew England Journal of Medicine, 1991
- Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: Reversal of deleterious effects of steroids on lipidsAmerican Journal Of Medicine, 1990
- Hydroxychloroquine in Decompensated, Treatment-Refractory Noninsulin-Dependent Diabetes MellitusAnnals of Internal Medicine, 1990